ACRV vs NIO · $65.1M cap vs rev $12.51B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US. It is led by Bin Li.
ACRV does not have a complete income-statement cache yet.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
ACRV currently screens at market cap $65.1M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the ACRV and NIO stock pages for the full models.
Not investment advice.